featured
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated PAH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial
Am J Respir Crit Care Med 2021 Mar 02;[EPub Ahead of Print], RT Zamanian, D Badesch, L Chung, RT Domsic, T Medsger, A Pinckney, L Keyes-Elstein, C D'Aveta, M Spychala, RJ White, PM Hassoun, F Torres, AJ Sweatt, JA Molitor, D Khanna, H Maecker, B Welch, E Goldmuntz, MR NicollsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.